RA Capital Management »

Century Therapeutics shares owned by RA Capital Management

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $40M 18M 2.26
2022-06-30 $6.4M 757k 8.40
2022-03-31 $12M 914k 12.59
2021-12-31 $15M 914k 15.86
2021-09-30 $23M 914k 25.16
2021-06-30 $27M 914k 29.34

More positions owned by RA Capital Management

Ascendis Pharma A/s - Sponsored Adr (ASND)
Vaxcyte Common Stock (PCVX)
Rhythm Pharmaceuticals Common Stock (RYTM)
Tyra Biosciences Common Stock (TYRA)
Sionna Therapeutics Common Stock (SION)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Nuvalent Inc-a Common Stock (NUVL)
Dianthus Therapeutics Common Stock (DNTH)
Mineralys Therapeutics Common Stock (MLYS)
Spyglass Pharma Common Stock
Wave Life Sciences Common Stock (WVE)
Septerna Common Stock (SEPN)
Disc Medicine Common Stock (IRON)
Janux Therapeutics Common Stock (JANX)

View all positions for RA Capital Management

Top funds holding Century Therapeutics

RA Capital Management
TCG Crossover Management
Versant Venture Management
Deep Track Capital
Commodore Capital
VR Adviser
Point72 Asset Management
Vanguard Capital Management
Balyasny Asset Management
Millennium Management
Woodline Partners
Seven Fleet Capital Management
Trails Edge Capital Partners
DAFNA Capital Management
Two Sigma Investments

View all funds holding Century Therapeutics